Literature DB >> 29979336

Mycoplasma genitalium Infections With Macrolide and Fluoroquinolone Resistance-Associated Mutations in Heterosexual African American Couples in Alabama.

Li Xiao1, Ken B Waites2, Barbara Van Der Pol3, Kristal J Aaron3, Edward W Hook3, William M Geisler3.   

Abstract

BACKGROUND: Mycoplasma genitalium (MG) is a sexually transmitted pathogen associated with inflammatory syndromes in men and women. Macrolides and fluoroquinolones are recommended MG treatments. The frequency of MG strains with macrolide resistance-associated mutations (MRMs) and quinolone resistance-associated mutations (qRMs) is increasing worldwide, however these data are sparse in populations in the United States.
METHODS: We investigated the prevalence of MG infections with MRMs and qRMs and MG infection concordance within African American couples in Birmingham, AL. We used a real-time polymerase chain reaction to detect MG and identify MRMs. quinolone resistance-associated mutations were detected using traditional polymerase chain reactions amplifying regions in gyrA, gyrB, parC, and parE. The MG concordance in couples was evaluated by MG positivity and MG genotypes.
RESULTS: Oral, anal, urine, and/or vaginal specimens were tested from 116 couples. Twenty-eight (12.1%) participants comprising 22 couples tested MG-positive (11.2% in men and 12.9% in women). Macrolide resistance-associated mutations were detected in 17 (60.7%) MG-positive participants, with gender-specific resistance rates of 69.2% for men and 53.3% for women. quinolone resistance-associated mutations were detected in 3 (11.1%) MG-positive participants, all of whom also had MRMs. By MG positivity status, 27.3% of couples were concordant. If MG strain genotypes are also considered, then concordance was 20.0%.
CONCLUSIONS: Among heterosexual African Americans with MG infection, about 60% had strains with MRMs and 11% had strains with both MRMs and qRMs, highlighting the potential for MG treatment failure to not only macrolides, but also quinolones. These findings may help to guide clinicians in MG testing and treatment decisions in the United States.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29979336      PMCID: PMC6289787          DOI: 10.1097/OLQ.0000000000000891

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  48 in total

Review 1.  Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis.

Authors:  Rebecca Lis; Ali Rowhani-Rahbar; Lisa E Manhart
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

2.  Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany.

Authors:  Roger Dumke; Alexander Thürmer; Enno Jacobs
Journal:  Diagn Microbiol Infect Dis       Date:  2016-07-08       Impact factor: 2.803

3.  Emergence of clinical strains of Mycoplasma genitalium harbouring alterations in ParC associated with fluoroquinolone resistance.

Authors:  Yasushi Shimada; Takashi Deguchi; Keita Nakane; Takako Masue; Mitsuru Yasuda; Shigeaki Yokoi; Shin-ichi Ito; Masahiro Nakano; Shin Ito; Hiroaki Ishiko
Journal:  Int J Antimicrob Agents       Date:  2010-06-30       Impact factor: 5.283

4.  Loop-mediated isothermal amplification (LAMP) for the rapid detection of Mycoplasma genitalium.

Authors:  Thomas Edwards; Patricia Burke; Helen B Smalley; Liz Gillies; Denise Longhurst; Barry Vipond; Glyn Hobbs
Journal:  Diagn Microbiol Infect Dis       Date:  2015-05-27       Impact factor: 2.803

5.  Remarkable increase in fluoroquinolone-resistant Mycoplasma genitalium in Japan.

Authors:  Mina Kikuchi; Shin Ito; Mitsuru Yasuda; Tomohiro Tsuchiya; Kyoko Hatazaki; Masaki Takanashi; Takayuki Ezaki; Takashi Deguchi
Journal:  J Antimicrob Chemother       Date:  2014-06-02       Impact factor: 5.790

6.  Mycoplasma genitalium among adolescent women and their partners.

Authors:  Aneesh K Tosh; Barbara Van Der Pol; J Dennis Fortenberry; James A Williams; Barry P Katz; Byron E Batteiger; Donald P Orr
Journal:  J Adolesc Health       Date:  2007-02-15       Impact factor: 5.012

Review 7.  The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis.

Authors:  Andrew Lau; Catriona S Bradshaw; Dyani Lewis; Christopher K Fairley; Marcus Y Chen; Fabian Y S Kong; Jane S Hocking
Journal:  Clin Infect Dis       Date:  2015-08-03       Impact factor: 9.079

8.  High Prevalence of Multidrug-Resistant Mycoplasma genitalium in Human Immunodeficiency Virus-Infected Men Who Have Sex With Men in Alabama.

Authors:  Jodie Dionne-Odom; William M Geisler; Kristal J Aaron; Ken B Waites; Andrew O Westfall; Barbara Van Der Pol; Li Xiao
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

9.  Fluoroquinolone-Resistant Mycoplasma genitalium, Southwestern France.

Authors:  Chloé Le Roy; Nadège Hénin; Sabine Pereyre; Cécile Bébéar
Journal:  Emerg Infect Dis       Date:  2016-09       Impact factor: 6.883

10.  Mutations in ParC and GyrA of moxifloxacin-resistant and susceptible Mycoplasma genitalium strains.

Authors:  Ryoichi Hamasuna; Phuong Thi Le; Satoshi Kutsuna; Keiichi Furubayashi; Masahiro Matsumoto; Norio Ohmagari; Naohiro Fujimoto; Tetsuro Matsumoto; Jorgen Skov Jensen
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

View more
  9 in total

1.  Lack of Association Between the S83I ParC Mutation in Mycoplasma genitalium and Treatment Outcomes Among Men Who Have Sex With Men with Nongonococcal Urethritis.

Authors:  Laura C Chambers; Jørgen S Jensen; Jennifer L Morgan; M Sylvan Lowens; Sarah S Romano; Patricia A Totten; Olusegun O Soge; James P Hughes; Matthew R Golden; Lisa E Manhart
Journal:  Sex Transm Dis       Date:  2019-12       Impact factor: 2.830

2.  Disseminated Mycoplasma Orale Infection in Patients With Phosphoinositide-3-Kinase Regulatory Subunit 1 Mutations.

Authors:  Arthur H Totten; Gulbu Uzel; Pavel P Khil; Jung-Ho Youn; Jennifer Treat; Craig D Soutar; Steven M Holland; John P Dekker; Christa S Zerbe
Journal:  Open Forum Infect Dis       Date:  2022-09-12       Impact factor: 4.423

Review 3.  Molecular Tools for Typing Mycoplasma pneumoniae and Mycoplasma genitalium.

Authors:  Roger Dumke
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064

4.  Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa.

Authors:  Liteboho D Maduna; Marleen M Kock; Brian M J W van der Veer; Oscar Radebe; James McIntyre; Lieke B van Alphen; Remco P H Peters
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

5.  Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection.

Authors:  Sally A Harrison; Kristin M Olson; Amy E Ratliff; Li Xiao; Barbara Van Der Pol; Ken B Waites; William M Geisler
Journal:  Sex Transm Dis       Date:  2019-10       Impact factor: 2.830

6.  Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium.

Authors:  Duygu Durukan; Michelle Doyle; Gerald Murray; Kaveesha Bodiyabadu; Lenka Vodstrcil; Eric P F Chow; Jorgen S Jensen; Christopher K Fairley; Ivette Aguirre; Catriona S Bradshaw
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

Review 7.  Mycoplasma genitalium infection in women reporting dysuria: A pilot study and review of the literature.

Authors:  Elizabeth Olson; Kanupriya Gupta; Barbara Van Der Pol; James W Galbraith; William M Geisler
Journal:  Int J STD AIDS       Date:  2021-07-06       Impact factor: 1.359

8.  Mycoplasma genitalium Biofilms Contain Poly-GlcNAc and Contribute to Antibiotic Resistance.

Authors:  James M Daubenspeck; Arthur H Totten; Jason Needham; Monica Feng; Mitchell F Balish; T Prescott Atkinson; Kevin Dybvig
Journal:  Front Microbiol       Date:  2020-10-27       Impact factor: 5.640

9.  Burden of Mycoplasma genitalium and Bacterial Coinfections in a Population-Based Sample in New Mexico.

Authors:  Anne Hammer; Patti E Gravitt; Rachael Adcock; Nicole Patterson; Jack Cuzick; Cosette M Wheeler
Journal:  Sex Transm Dis       Date:  2021-12-01       Impact factor: 2.830

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.